MedPath

Effect of foot massage with lavender essential oil in comparison to paraffin oil on restless legs syndrome (RLS) and anxiety levels

Not Applicable
Recruiting
Conditions
Restless legs syndrome
anxiety levels.
G25.81
Registration Number
IRCT20210523051370N7
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

Aged 18-65 years
Willingness to participate in the study
Being conscious (oriented to place, person and time)
Continuous treatment with hemodialysis (HD), three times a week for the last 6 months
Ability to walk on affected legs independently
Having symptoms of restless legs syndrome at least twice a week

Exclusion Criteria

Allergic to herbal plants (including essential oils and herbal extracts)
Any nervous system, vascular, skeletal and muscular disorders/abnormalities in the lower limbs
Simultaneous participation in other research studies investigating the relief of restless legs syndrome
History of drug and alcohol abuse
Any mental illness, dementia, and intellectual impairment
History of deep vein thrombosis
Pregnancy and breastfeeding
Use of psychiatric and neurological medications
Use of other herbal products to relieve Restless Legs Syndrome
Withdrawal criteria: Patient's death; Transfer to other hemodialysis centers; Emergency hemodialysis; Any side effects related to the intervention; Missing two hemodialysis sessions; Any interaction between the intervention and patients' medical and nursing care; Unwillingness to continue participation; Eligibility criteria violation.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Restless Legs Syndrome. Timepoint: Baseline (before intervention: T0); Follow-ups (after 6th session: T1; a week after the 6th session: T2). Method of measurement: International Restless Legs Severity Scale.
Secondary Outcome Measures
NameTimeMethod
Anxiety levels. Timepoint: Baseline (before intervention: T0); Follow-ups (after 6th session: T1; a week after the 6th session: T2). Method of measurement: HADS-anxiety.
© Copyright 2025. All Rights Reserved by MedPath